GREAT POINT PARTNERS LLC

CIK: 0001281446Latest portfolio: $308.4M · Q4 2025

Holdings

29

Total Value

$308.4M

New Positions

12

Closed Positions

13

#StockSharesValue% PortfolioChangeType
1
APGEAPOGEE THERAPEUTICS INC
374,000$28.2M9.15%+70K
2
AMLXAMYLYX PHARMACEUTICALS INC
1,750,000$21.1M6.85%+50K
3
ZURAZURA BIO LTD
3,815,930$20.0M6.48%
4
IRONDISC MEDICINE INC
250,000$19.9M6.44%NEW
5
RAPTRAPT THERAPEUTICS INC
581,187$19.7M6.38%NEW
6
IMVTIMMUNOVANT INC
750,000$19.1M6.18%+250K
7
SLNOSOLENO THERAPEUTICS INC
400,000$18.5M6.00%+175K
8
VORVOR BIOPHARMA INC
1,370,107$17.9M5.81%NEW
9
DNTHDIANTHUS THERAPEUTICS INC
350,000$14.4M4.68%+84K
10
JBIOJADE BIOSCIENCES INC
806,273$12.4M4.03%+174K
11
KALVKALVISTA PHARMACEUTICALS INC
685,632$11.1M3.59%NEW
12
CTNMCONTINEUM THERAPEUTICS INC
800,000$9.1M2.96%NEW
13
EPRXEUPRAXIA PHARMACEUTICALS INC
1,200,000$9.1M2.94%
14
FULCFULCRUM THERAPEUTICS INC
800,000$9.0M2.93%NEW
15
NKTRNEKTAR THERAPEUTICS
210,732$8.9M2.89%-89,268
16
UPBUPSTREAM BIO INC
300,000$8.1M2.64%
17
NGNENEUROGENE INC
350,000$7.2M2.34%-96,814
18
RAREULTRAGENYX PHARMACEUTICAL IN
300,000$6.9M2.24%NEW
19
CNTXCONTEXT THERAPEUTICS INC
4,683,711$6.9M2.23%
20
CGEMCULLINAN THERAPEUTICS INC
634,032$6.6M2.13%NEW
21
EVMNEVOMMUNE INC
325,000$5.6M1.80%NEW
22
ORKAORUKA THERAPEUTICS INC
183,330$5.6M1.80%
23
SLNSILENCE THERAPEUTICS PLC
808,032$4.9M1.59%NEW
24
UNCYUNICYCIVE THERAPEUTICS INC
796,558$4.6M1.49%
25
CLYMCLIMB BIO INC
979,534$3.9M1.27%NEW

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
IMVT750K+250K
SLNO400K+175K
JBIO806K+174K
DNTH350K+84K
APGE374K+70K
AMLX1.8M+50K
PHVS83K+-72305
RZLT952K+-1500000

Decreased Positions

NameSharesChange
NGNE350K-96814
NKTR211K-89268

Sector Breakdown

Healthcare100.0% ($2.822921140199952e+117T)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 17, 2026$308.4M29
Q3 2025Nov 14, 2025$242.5B30
Q2 2025Aug 14, 2025$153.8B26
Q1 2025May 15, 2025$188.8B32
Q4 2024Feb 14, 2025$212.2B26

Fund Information

CIK0001281446
Most Recent FilingFeb 17, 2026
Number of Filings5

GREAT POINT PARTNERS LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $308.4M across 29 holdings. The largest position is APOGEE THERAPEUTICS INC (APGE), representing 9.2% of the portfolio. Compared to the previous quarter, the fund opened 12 new positions and closed 13 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.